This page includes the latest FDA filings for Amylyx Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Amylyx Pharmaceuticals Inc | Prescription Medication | 2024-10-12 |
Amylyx Pharmaceuticals Inc | Prescription Medication | 2024-01-03 |
Amylyx Pharmaceuticals Inc | Prescription Medication | 2023-10-19 |
Amylyx Pharmaceuticals Inc | Prescription Medication | 2023-09-26 |
Amylyx Pharmaceuticals Inc | Prescription Medication | 2023-04-04 |
Amylyx Pharmaceuticals Inc | Prescription Medication | 2022-10-12 |
Amylyx Pharmaceuticals Inc | RELYVRIO | 2022-09-29 |
NCAGE Code | 7ZTZ1 | AMYLYX PHARMACEUTICALS, INC.!DBA AMYLYX |
CAGE Code | 7ZTZ1 | AMYLYX PHARMACEUTICALS, INC. AMYLYX |
S.A.M. Registration | 7ZTZ1 [80954012] | AMYLYX PHARMACEUTICALS, INC. AMYLYX |
SEC | 0001658551 | Amylyx Pharmaceuticals, Inc. of DELAWARE |